No Abbott Product
Device
Abbott Laboratories
Total Payments
$46,816
Transactions
21
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $46,816 | 21 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $46,816 | 21 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device | Abbott Laboratories | $28,647 | 0 |
| Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule, Zephir Inhaler Device | Abbott Laboratories | $16,275 | 0 |
| Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma | Abbott Laboratories | $1,894 | 0 |
Top Doctors Receiving Payments for No Abbott Product
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Orlando, FL | $46,816 | 21 |
Ad
Manufacturing Companies
- Abbott Laboratories $46,816
Product Information
- Type Device
- Total Payments $46,816
- Total Doctors 0
- Transactions 21
About No Abbott Product
No Abbott Product is a device associated with $46,816 in payments to 0 healthcare providers, recorded across 21 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2024 to 2024. In 2024, $46,816 was paid across 21 transactions to 0 doctors.
The most common payment nature for No Abbott Product is "Unspecified" ($46,816, 100.0% of total).
No Abbott Product is associated with 3 research studies, including "Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device" ($28,647).